Reuters: Health
The U.S. Food and Drug Administration declined to approve AstraZeneca Plc's combination therapy to treat smoker's lung, the drugmaker said on Tuesday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
Popular Posts
|
No comments:
Post a Comment